Leiomyosarcoma of the small and large bowel

Area of Science:

• Gastroenterology
• Surgical Oncology
• Pathology

Background:

• Primary intestinal leiomyosarcoma is a rare gastrointestinal malignancy.
• Understanding its epidemiology and clinical behavior is crucial for patient management.

Purpose of the Study:

• To analyze the clinical characteristics, treatment outcomes, and survival rates of primary intestinal leiomyosarcoma.
• To identify prognostic factors influencing patient survival.

Main Methods:

• Retrospective review of 108 cases of primary intestinal leiomyosarcoma diagnosed at the Mayo Clinic between 1950 and 1974.
• Analysis of patient demographics, tumor location, presenting symptoms, surgical resection rates, and survival data.

Main Results:

• The majority of tumors (73%) were located in the small bowel.
• Gastrointestinal bleeding and pain were the most frequent presenting symptoms, necessitating surgical exploration.
• Only 48% of tumors were resectable with curative intent; 5-year and 10-year survival rates were 50% and 35%, respectively, with frequent late recurrences.
• Histologic grade influenced prognosis.

Conclusions:

• Primary intestinal leiomyosarcoma is a challenging malignancy with a guarded prognosis, often characterized by late recurrences.
• Early diagnosis and complete surgical resection are critical for improving patient outcomes.
• Histologic grading is an important prognostic indicator.